NCT00454220View on ClinicalTrials.gov

Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Multinodular Goiter
Interventions
OTHER

Placebo

33 patients to placebo + 131-I arm

DRUG

MRrhTSH

33 patients to 0.01 mg MRrhTSH + 131-I arm

DRUG

MRrhTSH

33 patients to 0.03 mg MRrhTSH + 131-I arm

Trial Locations (11)

Unknown

Boston

Curitiba

Rio de Janeiro

London

Toronto

Odense

Lille

Würzburg

Pisa

Siena

Netherlands

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00454220 - Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter | Biotech Hunter | Biotech Hunter